guest ::
| Home > Publications database > Small-area analysis on socioeconomic inequalities in cancer survival for 25 cancer sites in Germany. > print |
| Home > Publications database > Small-area analysis on socioeconomic inequalities in cancer survival for 25 cancer sites in Germany. > print |
| 001 | 168120 | ||
| 005 | 20240229133557.0 | ||
| 024 | 7 | _ | |a 10.1002/ijc.33553 |2 doi |
| 024 | 7 | _ | |a pmid:33751564 |2 pmid |
| 024 | 7 | _ | |a 0020-7136 |2 ISSN |
| 024 | 7 | _ | |a 1097-0215 |2 ISSN |
| 024 | 7 | _ | |a altmetric:103551825 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2021-00688 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Finke, Isabelle |0 P:(DE-He78)a79a61dd9934f6115f9383fd1dc21d76 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Small-area analysis on socioeconomic inequalities in cancer survival for 25 cancer sites in Germany. |
| 260 | _ | _ | |a Bognor Regis |c 2021 |b Wiley-Liss |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1637161221_27175 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:C070#LA:C070# /149(3):561-572 |
| 520 | _ | _ | |a Socioeconomic inequalities in cancer survival have been reported in various countries but it is uncertain to what extent they persist in countries with relatively comprehensive health insurance coverage such as Germany. We investigated the association between area-based socioeconomic deprivation on municipality level and cancer survival for 25 cancer sites in Germany. We used data from seven population-based cancer registries (covering 32 million inhabitants). Patients diagnosed in 1998-2014 with one of 25 most common cancer sites were included. Area-based socioeconomic deprivation was assessed using the categorized German Index of Multiple Deprivation (GIMD) on municipality level. We estimated 3-month, 1-year, 5-year and 5-year conditional on 1-year age-standardized relative survival using period approach for 2012-2014. Trend analyses were conducted for periods between 2003-2005 and 2012-2014. Model-based period analysis was used to calculate relative excess risks (RER) adjusted for age and stage. In total, 2,333,547 cases were included. For all cancers combined, 5-year survival rates by GIMD quintile were 61.6% in Q1 (least deprived), 61.2% in Q2, 60.4% in Q3, 59.9% in Q4, and 59.0% in Q5 (most deprived). For most cancer sites, the most deprived quintile had lower 5-year survival compared to the least deprived quintile even after adjusting for stage (all cancer sites combined, RER 1.16, 95% confidence interval 1.14-1.19). For some cancer sites, this association was stronger during short-term follow-up. Trend analyses showed improved survival from earlier to recent periods but persisting deprivation differences. The underlying reasons for these persisting survival inequalities and strategies to overcome them should be further investigated. |
| 536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Area-based socioeconomic deprivation |2 Other |
| 650 | _ | 7 | |a Germany |2 Other |
| 650 | _ | 7 | |a cancer registry |2 Other |
| 650 | _ | 7 | |a survival |2 Other |
| 700 | 1 | _ | |a Behrens, Gundula |0 P:(DE-He78)810dd5ca5d284a355124f982bfc3a8e6 |b 1 |u dkfz |
| 700 | 1 | _ | |a Maier, Werner |b 2 |
| 700 | 1 | _ | |a Schwettmann, Lars |b 3 |
| 700 | 1 | _ | |a Pritzkuleit, Ron |b 4 |
| 700 | 1 | _ | |a Holleczek, Bernd |b 5 |
| 700 | 1 | _ | |a Kajüter, Hiltraud |b 6 |
| 700 | 1 | _ | |a Gerken, Michael |b 7 |
| 700 | 1 | _ | |a Mattutat, Johann |b 8 |
| 700 | 1 | _ | |a Emrich, Katharina |b 9 |
| 700 | 1 | _ | |a Jansen, Lina |0 P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09 |b 10 |u dkfz |
| 700 | 1 | _ | |a Brenner, Hermann |0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |b 11 |u dkfz |
| 700 | 1 | _ | |a Group, German Cancer Survival Working |b 12 |e Collaboration Author |
| 700 | 1 | _ | |a Möller, Mark |b 13 |
| 700 | 1 | _ | |a Jäger, Karin |b 14 |
| 700 | 1 | _ | |a Werner, Carmen |b 15 |
| 700 | 1 | _ | |a Strecker, Paul |b 16 |
| 700 | 1 | _ | |a Gerken, Michael |b 17 |
| 700 | 1 | _ | |a Geiss, Karla |b 18 |
| 700 | 1 | _ | |a Twardella, Dorothee |b 19 |
| 700 | 1 | _ | |a Meyer, Martin |b 20 |
| 700 | 1 | _ | |a Eberle, Andrea |b 21 |
| 700 | 1 | _ | |a Luttmann, Sabine |b 22 |
| 700 | 1 | _ | |a Wilsdorf-Köhler, Heide |b 23 |
| 700 | 1 | _ | |a Stabenow, Roland |b 24 |
| 700 | 1 | _ | |a Erb, Cynthia |b 25 |
| 700 | 1 | _ | |a Nennecke, Alice |b 26 |
| 700 | 1 | _ | |a Hentschel, Stefan |b 27 |
| 700 | 1 | _ | |a Sirri, Eunice |b 28 |
| 700 | 1 | _ | |a Kieschke, Joachim |b 29 |
| 700 | 1 | _ | |a Holleczek, Bernd |b 30 |
| 700 | 1 | _ | |a Emrich, Katharina |b 31 |
| 700 | 1 | _ | |a Kajüter, Hiltraud |b 32 |
| 700 | 1 | _ | |a Mattauch, Volkmar |b 33 |
| 700 | 1 | _ | |a Katalinic, Alexander |b 34 |
| 700 | 1 | _ | |a Pritzkuleit, Ron |b 35 |
| 700 | 1 | _ | |a Mattutat, Johann |b 36 |
| 700 | 1 | _ | |a Arndt, Volker |b 37 |
| 700 | 1 | _ | |a Maier, Werner |b 38 |
| 700 | 1 | _ | |a Schwettmann, Lars |b 39 |
| 700 | 1 | _ | |a Brenner, Hermann |0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |b 40 |u dkfz |
| 700 | 1 | _ | |a Behrens, Gundula |b 41 |
| 700 | 1 | _ | |a Jansen, Lina |0 P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09 |b 42 |u dkfz |
| 700 | 1 | _ | |a Finke, Isabelle |b 43 |
| 773 | _ | _ | |a 10.1002/ijc.33553 |g p. ijc.33553 |0 PERI:(DE-600)1474822-8 |n 3 |p 561-572 |t International journal of cancer |v 149 |y 2021 |x 1097-0215 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:168120 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)a79a61dd9934f6115f9383fd1dc21d76 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)810dd5ca5d284a355124f982bfc3a8e6 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 40 |6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 42 |6 P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Cancer risk factors and prevention |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2021-02-04 |w ger |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2021-02-04 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-04 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-02-04 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b INT J CANCER : 2019 |d 2021-02-04 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b INT J CANCER : 2019 |d 2021-02-04 |
| 920 | 1 | _ | |0 I:(DE-He78)C070-20160331 |k C070 |l C070 Klinische Epidemiologie und Alternf. |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)C120-20160331 |k C120 |l Präventive Onkologie |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C070-20160331 |
| 980 | _ | _ | |a I:(DE-He78)C120-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|